LUP.STU Luye Pharma Group Ltd

- EUR
Market cap
-
P/E
17.8x
P/B
0.33x
ROE
3.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is LUP.STU undervalued?

Graham number

The Graham number of Luye Pharma Group Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Luye Pharma Group Ltd fundamental analysis

No fundamental analysis for Luye Pharma Group Ltd yet.

Luye Pharma Group Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.